Found 10 matching trials
Zalutumumab in Non-curable Patients With SCCHN
PHASE2Treatment, In combination with BSC, Open-label, Single arm, Efficacy Study....
Location
University of Alabama at Birmingham
Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer
PHASE1The purpose of this study is to investigate the safety of zalutumumab in co...
Location
Oregon Health Sciences Center
Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer
PHASE1The purpose of this trial is to determine the safety and efficacy of Zalutu...
Location
Institut Jules Bordet
DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC
PHASE3The purpose of this study is to determine whether the addition of the fully...
Location
Department of Experimental Clinical Oncology, Aarhus University Hospital
Zalutumumab in Patients With Non-curable Head and Neck Cancer
PHASE3The purpose of this study is to investigate if zalutumumab in combination w...
Location
University Hospital Antwerp
Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)
PHASE1This study is to support current and future Zalutumumab studies by increasi...
Location
Cliniques Universitaires SaintLuc
Zalutumumab in Non-Small Cell Lung Cancer (NSCLC) Patients Refractory to Tyrosine Kinase Inhibitors
PHASE2A Single-arm Phase II Trial Investigating the Efficacy and Safety of Zalutu...
Location
Multiple Locations
Zalutumumab in Head and Neck Cancer
PHASE1The purpose of this trial is to determine the safety of zalutumumab as a tr...
Location
Århus Kommunehospital
Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy
PHASE1The purpose of this study is to investigate the safety of zalutumumab in co...
Location
St-Luc University Hospital
Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer
PHASE2The purpose of the study is to investigate if treatment with zalutumumab in...
Location
Multiple Locations